Azra AI key facts
as of Oct 2026- Developer of an AI-powered platform designed to automate workflows and coordinate care across oncology and critical service lines.
- Azra AI is valued at approximately $235.0M as of Oct 2026 (last reported valuation).
- It has raised $18.9M; the latest was Later Stage VC ($11.0M) in Jan 2026.
- Notable investors include SJF Ventures, FCA Venture Partners, NewHealth Ventures, Sopris Venture Capital.
- Status: Privately Held (backing).
Azra AI's last reported valuation, Jan 2026. Nothing priced has surfaced since.
- ·Watch Azra AI: the Monday email on marks, rounds and moves
Azra AI funding rounds
No funding rounds for Azra AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Azra AI
4Azra AI valuation
Azra AI's last reported valuation was $235 million in Jan 2026. No priced round, secondary trade or fund mark has surfaced since.
Azra AI investors
4 investors are on record for Azra AI, including SJF Ventures, FCA Venture Partners, NewHealth Ventures and Sopris Venture Capital.
About Azra AI
Developer of an AI-powered platform designed to automate workflows and coordinate care across oncology and critical service lines. The company offers real-time analysis of pathology and radiology reports, ADT feeds, and clinical data, enabling hospitals to identify patients earlier, connect them to coordinated care faster, and manage treatment journeys more efficiently.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2021
- Employees
- 42
- Website
- azra-ai.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.